Is chemotherapy needed for stage IA3 invasive pulmonary adenocarcinoma?
May 11, 2023
Source: Cainiu Health
Dr. Qi Zhirong
Introduction
Whether chemotherapy is needed for stage IA3 invasive lung adenocarcinoma should be determined based on the patient's individual physical condition. If the patient can tolerate surgery, chemotherapy is generally not required. However, if there are contraindications to surgery or the patient cannot tolerate surgical intervention, chemotherapy may be used to prevent disease dissemination and metastasis. Commonly used chemotherapeutic agents include paclitaxel injection and carboplatin injection.
Invasive lung adenocarcinoma stage IA3 may or may not require chemotherapy, depending on the patient's individual physical condition. If surgery can be tolerated, chemotherapy is generally not needed; however, if there are contraindications to surgery, chemotherapy is usually required. Details are as follows:
1. Chemotherapy required
Stage IA3 invasive lung adenocarcinoma is an early-stage disease in which the lesion is relatively localized. If the patient has a strong immune system and good physical resistance, surgical treatment is typically recommended. Common surgical procedures include lobectomy and wedge resection. After successful surgery, the lesion can usually be completely removed, and additional chemotherapy is not necessary.
2. Chemotherapy not required
If the patient has severe renal insufficiency, frequent angina attacks within the past three months, or poor overall health that makes surgery intolerable, chemotherapy may be used to prevent disease progression and metastasis. Commonly used chemotherapeutic agents include paclitaxel injection, carboplatin injection, and shunfeng injection.
Patients should promptly visit the oncology department of a reputable hospital and, under a doctor’s guidance, select an appropriate treatment method. During treatment, adequate rest and sufficient sleep should also be maintained.
